Actinium Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -189 | -216 | ||
EBITDA | -7,301 | -12,399 | -12,229 | -9,381 |
EBIT | -7,505 | -12,601 | -12,418 | -9,597 |
Net Income | -6,652 | -11,568 | -11,353 | -8,670 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,751 | -11,975 | -7,972 | -7,385 |
Cash | 72,904 | 78,660 | 86,037 | 84,057 |
Basic Shares | 30,070 | 31,071 | 30,103 | 27,886 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $81 | $1,030 | $1,144 |
Gross Profit | 81 | 331 | 620 | |
EBITDA | -42,121 | -51,130 | -33,405 | -24,440 |
EBIT | -51,920 | -34,104 | -24,964 | |
Net Income | -38,243 | -48,818 | -31,930 | -24,584 |
Net Change In Cash | 0 | 81 | 1,030 | 1,144 |
Cost of Revenue | 14,222 | |||
Free Cash Flow | -33,083 | -47,488 | 8,278 | -20,999 |
Cash | 72,904 | 76,677 | 108,910 | 77,829 |
Basic Shares | 30,070 | 26,604 | 24,141 | 20,568 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.21 |
2024-09-30 | -$0.37 |
2024-06-30 | -$0.38 |
2024-03-31 | -$0.31 |
